Symbiosis Pharmaceutical Services, a global CDMO specializing in the GMP sterile fill-finish manufacturing of injectable drug products, has appointed Joanne Anderson as Chief Commercial Officer. 

Joanne brings more than 25 years of pharmaceutical industry experience. Most recently she served as Global Key Account Director at Recipharm and previously with other global CDMOs. 

The strategic appointment is also significant for Anderson, who returns to Symbiosis after six years away, to lead their global commercial team.

The appointment comes at a time of growth for the company. Following a period of significant investment in its manufacturing capacity and the recent successful qualification of its new commercial production facility, Symbiosis aims to meet the rising global demand for specialized GMP sterile fill-finish manufacturing. 

Colin MacKay, CEO of Symbiosis, said, “We are delighted to welcome Joanne back to the leadership team at such an exciting time for the business. Her intrinsic understanding of our clients needs, Symbiosis technical capabilities and our commitment to quality, coupled with her extensive global industry network, makes her the ideal leader to spearhead our commercial growth.”

“As we look to expand our footprint in North America, Europe and beyond, Joanne’s vision will be instrumental in ensuring Symbiosis remains the partner of choice for innovative drug developers worldwide.”